Pharmafile Logo

Striving to become more patient-centric?

August 25, 2020 |  

Explore more with OPEN Health

Patients are increasingly involved in their healthcare decisions. They have become empowered and informed data-driven advocates for their own health. We are currently at a tipping point in the industry as regulatory bodies and patient advocacy groups have come together to reinforce the importance of the role of patients in the drug development process.

Why now?

  • Patient engagement tools have evolved considerably
  • There is an increased role of patients in regulatory and health technology decision making
  • Healthcare players who are unable or unwilling to deepen collaborations in the industry may find it difficult, if not impossible, to participate in a future patient-driven healthcare system

But how does a patient-centric approach evolve from a one-off engagement tactic to a fully integrated, company-wide practice?

Join us and take an interactive tour through today’s modern approach to patient-centricity. We will show how patient-centricity can be integrated into all phases of development and commercialization and show examples of how to achieve patient buy-in and ensure the patient voice is represented in your study outcomes.

Start Your Journey

In this interactive journey, you will:

  • Learn about the value of a patient-centric approach
  • Explore areas to focus on at different phases of the product life cycle
  • See real-life case studies of how a patient-centric approach can be used in therapeutic areas such as oncology, rare disease and advanced therapies
  • Find out how to take your first step to a patient-centric approach
  • Meet our team of experts and what drives them

Pink divider

Pharmerit – an OPEN Health Company has been at the forefront of the evolution of patient-centricity. We have seen the positive impact of engaging patients throughout the product lifecycle. We believe it is important to include patient-centricity in every project we undertake, combining expertise with outcomes to see the impact of co-creation.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing

OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

Spotlight interview: 15 minutes on the procurement function in pharma

Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.

Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...

OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director

OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...

OPEN Health Graduates and the XP Support Group

During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...